American Century Companies’s Lyell Immunopharma LYEL Stock Holding History
Bought
Maintained
Sold
Other funds holding LYEL
AVM
GP
FCMI
OPL
VCM
DC
AC
FCMV
American Century Companies's LYEL Position: Q1 2026 in Review
American Century Companies opened a new position in Lyell Immunopharma (LYEL) in Q1 2026: 15,971 shares worth $320K. The stake represents ﹤0.01% of the portfolio and ranks #2625 among its holdings. This is a return to the name: American Century Companies previously reported a position in LYEL as recently as Q2 2024.
American Century Companies first reported a position in LYEL in Q3 2022 and has held it in 9 quarters since. The position peaked at $528K in Q1 2024. 74 funds tracked by Wall St. Rank hold LYEL as of Q1 2026.
- American Century Companies held 15,971 shares of Lyell Immunopharma worth $320K as of Q1 2026.
- Lyell Immunopharma was a new American Century Companies position in Q1 2026.
- Lyell Immunopharma made up ﹤0.01% of American Century Companies's portfolio in Q1 2026, its #2625 holding.
- American Century Companies first reported a position in Lyell Immunopharma in Q3 2022 and has held it in 9 quarters since.
- American Century Companies's Lyell Immunopharma position peaked at $528K in Q1 2024.
- 74 funds tracked by Wall St. Rank held Lyell Immunopharma as of Q1 2026.
Based on American Century Companies's 13F filing for Q1 2026, filed 15 May 2026.